JAMA - Lung cancer screening decision aid delivered through tobacco quitlines improves informed deci
Monday, February 3, 2020
Posted by: Natalia Gromov
Dear Colleagues,
In a study published on January 31, 2020 in JAMA Network Open, researchers from the University of Texas MD Anderson Cancer Center have shown that a patient decision aid delivered through state tobacco quitlines effectively reached an eligible population and helped inform their decisions about lung cancer screening. Smokers who received the decision aid were better prepared to make a decision and had greater lung cancer screening knowledge.
These results were made possible by the participation of 13 state quitlines (AL, KY, MI, MS, NY, OH, PA, SC, TN, VT, VA, WA, and WY) and five service providers (ASHLine, IQH, National Jewish Health, Optum, and Roswell Park Cancer Institute), along with NAQC, in the MD Anderson study.
Lung cancer screening (LCS) is an effective intervention that has the potential to save 12,000 lives each year. The recent Surgeon Generals Report on Cessation mentions LCS as a critical life event that may encourage cessation (evidence is insuffient at this time). Links to the JAMA Network Open article and MD Anderson press release are below.
We encourage you to review the article and press release, and to consider the role of your quitline in making smokers more aware of LCS.
Article
Press Release
Another study authored by a NAQC member focused on using the state quitline to deliver opt-out smoking cessation services to cancer patients. In Michigan, a unique collaborative project targeting cancer patients showed that using statewide resources increased access to evidence-based smoking cessation assistance to patients with cancer.
Regards,
NAQC Staff
|
|
Email to a Friend